Colorectal Cancer Screening With Improved Shared Decision Making
CRCS-WISDM
2 other identifiers
interventional
206,721
1 country
1
Brief Summary
The purpose of this study is to increase colorectal cancer screening by implementing a community-wide shared decision-making (SDM) intervention, which embeds shared decision making within clinical practice and also uses an extensive community engagement campaign. The investigators hypothesize that colorectal cancer screening adherence will be higher in the intervention group (participating communities) compared to the usual care control group (non-participating comparison communities).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 13, 2012
CompletedFirst Posted
Study publicly available on registry
January 27, 2012
CompletedStudy Start
First participant enrolled
May 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 18, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 18, 2017
CompletedFebruary 4, 2019
January 1, 2019
5.2 years
January 13, 2012
January 31, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in colorectal cancer screening adherence
Colorectal cancer screening adherence will be defined as having screening according to the recommendations of the United States Preventive Services Task Force. Participants will be classified as screened per recommendations if they have had fecal occult blood testing in the last year, flexible sigmoidoscopy in the last five years, or colonoscopy in the last ten years. Participants will be classified as non-adherent if they have not had any of the modalities within the recommended timeframe.
Baseline up to 24 months post intervention initiation
Secondary Outcomes (5)
Decisional conflict
Baseline up to 24 months post intervention initiation
Modality-specific colorectal cancer screening barriers
Baseline up to 24 months post intervention initiation
Colorectal cancer screening-related confusion
Baseline up to 24 months post intervention initiation
Patients' shared decision-making experience
Baseline up to 12 months post intervention initiation
Providers'/staff shared decision-making experience
Baseline up to 24 months post intervention initiation
Study Arms (2)
Shared Decision Making
EXPERIMENTALComparison (control)
NO INTERVENTIONInterventions
Age-eligible adults in the intervention communities will be exposed to the shared decision-making intervention when they are seen in the primary care clinics (N=all patients 50-75 years seen during the study period who are non-adherent to CRCS recommendation). Additionally, among patients with primary care visits scheduled one week or more before the visit, they will be randomized to receive either a mailed decision aid booklet or an informational flyer on shared decision making and CRCS prior to the visit. Patients with primary care visits scheduled less than one week prior to the visit will not be mailed materials in advance. The effect of the pre-visit materials on referral to SDM session and CRCS adherence between these groups will be compared. They will also be exposed to shared decision-making tools and resources available through the community-wide intervention activities.
Eligibility Criteria
You may qualify if:
- to 75 years of age
- Lives in or receives care in the selected intervention or comparison (control) communities
- Average-risk for colorectal cancer
- Non-adherent to CRCS recommendation
- English-speaking
- People who consent to participate
You may not qualify if:
- \<50 years of age or \>75 years of age
- Not living in or receiving care in the selected intervention or comparison communities
- High-risk for colorectal cancer
- Adherent to CRCS recommendation
- Non-English speaking
- People who do not consent to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Virginia Commonwealth Universitylead
- Allina Health Systemcollaborator
- Blue Cross Blue Shieldcollaborator
Study Sites (1)
Allina Health Systems - Commons
Minneapolis, Minnesota, 55404, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Resa M Jones, MPH, PhD
Virginia Commonwealth University and Temple University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 13, 2012
First Posted
January 27, 2012
Study Start
May 1, 2012
Primary Completion
July 18, 2017
Study Completion
July 18, 2017
Last Updated
February 4, 2019
Record last verified: 2019-01